Status:
TERMINATED
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Pharmacia Corp. (Peapack, NJ)
Boehringer Ingelheim
Conditions:
Parkinson's Disease
Eligibility:
All Genders
Brief Summary
To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole co...
Eligibility Criteria
Inclusion
- Available 301 subjects enrolled in the CALM-PD study.
Exclusion
- Those not enrolled in the CALM-PD study.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT00804479
Start Date
January 1 2002
End Date
March 1 2004
Last Update
January 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14620